Liposome-delivered angiostatin strongly inhibits tumor growth and metastatization in a transgenic model of spontaneous breast cancer

Maria Grazia Sacco, Mario Caniatti, Enrica Mira Catò, Annalisa Frattini, Giulia Chiesa, Roberta Ceruti, Fulvio Adorni, Luigi Zecca, Eugenio Scanziani, Paolo Vezzoni

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

The possibility to inhibit tumor growth by interfering with the formation of new vessels, which most neoplasias depend on, has recently raised considerable interest. An angiogenic switch, in which proliferating cells acquire the ability to direct new vessel formation, is thought to be an early step in the natural history of solid tumors. Using a transgenic model of breast cancer, which shows many similarities to its human counterpart, including ability to metastasize, we targeted angiostatin production to an early stage of tumor formation. Liposome-delivered angiostatin considerably delayed primary tumor growth and, more importantly, inhibited the appearance of lung metastases. These findings can be relevant to the design of therapeutic intervention in humans.

Original languageEnglish
Pages (from-to)2660-2665
Number of pages6
JournalCancer Research
Volume60
Issue number10
Publication statusPublished - May 15 2000

Fingerprint

Angiostatins
Liposomes
Breast Neoplasms
Growth
Neoplasms
Neoplasm Metastasis
Lung

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Sacco, M. G., Caniatti, M., Catò, E. M., Frattini, A., Chiesa, G., Ceruti, R., ... Vezzoni, P. (2000). Liposome-delivered angiostatin strongly inhibits tumor growth and metastatization in a transgenic model of spontaneous breast cancer. Cancer Research, 60(10), 2660-2665.

Liposome-delivered angiostatin strongly inhibits tumor growth and metastatization in a transgenic model of spontaneous breast cancer. / Sacco, Maria Grazia; Caniatti, Mario; Catò, Enrica Mira; Frattini, Annalisa; Chiesa, Giulia; Ceruti, Roberta; Adorni, Fulvio; Zecca, Luigi; Scanziani, Eugenio; Vezzoni, Paolo.

In: Cancer Research, Vol. 60, No. 10, 15.05.2000, p. 2660-2665.

Research output: Contribution to journalArticle

Sacco, MG, Caniatti, M, Catò, EM, Frattini, A, Chiesa, G, Ceruti, R, Adorni, F, Zecca, L, Scanziani, E & Vezzoni, P 2000, 'Liposome-delivered angiostatin strongly inhibits tumor growth and metastatization in a transgenic model of spontaneous breast cancer', Cancer Research, vol. 60, no. 10, pp. 2660-2665.
Sacco MG, Caniatti M, Catò EM, Frattini A, Chiesa G, Ceruti R et al. Liposome-delivered angiostatin strongly inhibits tumor growth and metastatization in a transgenic model of spontaneous breast cancer. Cancer Research. 2000 May 15;60(10):2660-2665.
Sacco, Maria Grazia ; Caniatti, Mario ; Catò, Enrica Mira ; Frattini, Annalisa ; Chiesa, Giulia ; Ceruti, Roberta ; Adorni, Fulvio ; Zecca, Luigi ; Scanziani, Eugenio ; Vezzoni, Paolo. / Liposome-delivered angiostatin strongly inhibits tumor growth and metastatization in a transgenic model of spontaneous breast cancer. In: Cancer Research. 2000 ; Vol. 60, No. 10. pp. 2660-2665.
@article{f9eaf68f17b945e5bcdbd5ae493a116f,
title = "Liposome-delivered angiostatin strongly inhibits tumor growth and metastatization in a transgenic model of spontaneous breast cancer",
abstract = "The possibility to inhibit tumor growth by interfering with the formation of new vessels, which most neoplasias depend on, has recently raised considerable interest. An angiogenic switch, in which proliferating cells acquire the ability to direct new vessel formation, is thought to be an early step in the natural history of solid tumors. Using a transgenic model of breast cancer, which shows many similarities to its human counterpart, including ability to metastasize, we targeted angiostatin production to an early stage of tumor formation. Liposome-delivered angiostatin considerably delayed primary tumor growth and, more importantly, inhibited the appearance of lung metastases. These findings can be relevant to the design of therapeutic intervention in humans.",
author = "Sacco, {Maria Grazia} and Mario Caniatti and Cat{\`o}, {Enrica Mira} and Annalisa Frattini and Giulia Chiesa and Roberta Ceruti and Fulvio Adorni and Luigi Zecca and Eugenio Scanziani and Paolo Vezzoni",
year = "2000",
month = "5",
day = "15",
language = "English",
volume = "60",
pages = "2660--2665",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "10",

}

TY - JOUR

T1 - Liposome-delivered angiostatin strongly inhibits tumor growth and metastatization in a transgenic model of spontaneous breast cancer

AU - Sacco, Maria Grazia

AU - Caniatti, Mario

AU - Catò, Enrica Mira

AU - Frattini, Annalisa

AU - Chiesa, Giulia

AU - Ceruti, Roberta

AU - Adorni, Fulvio

AU - Zecca, Luigi

AU - Scanziani, Eugenio

AU - Vezzoni, Paolo

PY - 2000/5/15

Y1 - 2000/5/15

N2 - The possibility to inhibit tumor growth by interfering with the formation of new vessels, which most neoplasias depend on, has recently raised considerable interest. An angiogenic switch, in which proliferating cells acquire the ability to direct new vessel formation, is thought to be an early step in the natural history of solid tumors. Using a transgenic model of breast cancer, which shows many similarities to its human counterpart, including ability to metastasize, we targeted angiostatin production to an early stage of tumor formation. Liposome-delivered angiostatin considerably delayed primary tumor growth and, more importantly, inhibited the appearance of lung metastases. These findings can be relevant to the design of therapeutic intervention in humans.

AB - The possibility to inhibit tumor growth by interfering with the formation of new vessels, which most neoplasias depend on, has recently raised considerable interest. An angiogenic switch, in which proliferating cells acquire the ability to direct new vessel formation, is thought to be an early step in the natural history of solid tumors. Using a transgenic model of breast cancer, which shows many similarities to its human counterpart, including ability to metastasize, we targeted angiostatin production to an early stage of tumor formation. Liposome-delivered angiostatin considerably delayed primary tumor growth and, more importantly, inhibited the appearance of lung metastases. These findings can be relevant to the design of therapeutic intervention in humans.

UR - http://www.scopus.com/inward/record.url?scp=0034657404&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034657404&partnerID=8YFLogxK

M3 - Article

C2 - 10825138

AN - SCOPUS:0034657404

VL - 60

SP - 2660

EP - 2665

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 10

ER -